跳至主要内容
临床试验/KCT0003822
KCT0003822
已完成
未知

A 12 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of KACC91563 on atopic dermatitis in children

Aram0 个研究点目标入组 100 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
Aram
入组人数
100
状态
已完成
最后更新
5年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
5年前
研究类型
Interventional Study
性别
All

研究者

发起方
Aram

入排标准

入选标准

  • 1\) The subjects and their parents(or legal representatives), who has agreed to participate in this study and voluntarily signed the Informed consent form
  • 2\) The subjects, who aged between 1 and 12 years
  • 3\) The subjects, who has intermittent or continuous atopic dermatitis more than 6 months

排除标准

  • 1\) The subjects with severe skin and systemic diseases other than atopic dermatitis
  • 2\) The subjects, who has administered systemic antibiotics, corticosteroids, antihistamines and immunosuppressants for atopic dermatitis within 1 week before the human application test.
  • 3\) The subjects, who is deemed unfit for this human application test by the Investigator

结局指标

主要结局

未指定

相似试验